Literature DB >> 28473729

Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Veaceslav Boldescu1,2, Mira A M Behnam1, Nikos Vasilakis3, Christian D Klein1.   

Abstract

Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging Zika virus, are an increasing and probably lasting global risk. This Review summarizes and comments on the opportunities for broad-spectrum agents that are active against multiple flaviviruses. Broad-spectrum activity is particularly desirable to prepare for the next flaviviral epidemic, which could emerge from as-yet unknown or neglected viruses. Potential molecular targets for broad-spectrum antiflaviviral compounds include viral proteins, such as the viral protease or polymerase, and host targets that are exploited by these viruses during entry and replication, including α-glucosidase and proteins involved in nucleoside biosynthesis. Numerous compounds with broad-spectrum antiviral activity have already been identified by target-specific or phenotypic assays. For other compounds, broad-spectrum activity can be anticipated because of their mode of action and molecular targets.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28473729      PMCID: PMC5925760          DOI: 10.1038/nrd.2017.33

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  320 in total

1.  Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.

Authors:  T J Chambers; A Grakoui; C M Rice
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Magnetic resonance imaging findings in Guillain-Barré syndrome caused by Zika virus infection.

Authors:  Cristina Asvolinsque Pantaleão Fontes; Alair Augusto S M Damas Dos Santos; Edson Marchiori
Journal:  Neuroradiology       Date:  2016-04-11       Impact factor: 2.804

3.  Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R-like Endoplasmic Reticulum Kinase and elevates levels of eIF2α phosphorylation in virus infected cells.

Authors:  J E Fraser; C Wang; K W K Chan; S G Vasudevan; D A Jans
Journal:  Antiviral Res       Date:  2016-03-08       Impact factor: 5.970

4.  A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.

Authors:  Wouter Schul; Wei Liu; Hao-Ying Xu; Marie Flamand; Subhash G Vasudevan
Journal:  J Infect Dis       Date:  2007-01-23       Impact factor: 5.226

5.  Humanized mice show clinical signs of dengue fever according to infecting virus genotype.

Authors:  Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

6.  Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.

Authors:  Dana L Swenson; Kelly L Warfield; Travis K Warren; Candace Lovejoy; Jed N Hassinger; Gordon Ruthel; Robert E Blouch; Hong M Moulton; Dwight D Weller; Patrick L Iversen; Sina Bavari
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models.

Authors:  Christopher Barton; J Calvin Kouokam; Amanda B Lasnik; Oded Foreman; Alexander Cambon; Guy Brock; David C Montefiori; Fakhrieh Vojdani; Alison A McCormick; Barry R O'Keefe; Kenneth E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

8.  Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013.

Authors:  E Oehler; L Watrin; P Larre; I Leparc-Goffart; S Lastere; F Valour; L Baudouin; Hp Mallet; D Musso; F Ghawche
Journal:  Euro Surveill       Date:  2014-03-06

9.  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.

Authors:  William G Glass; Jean K Lim; Rushina Cholera; Alexander G Pletnev; Ji-Liang Gao; Philip M Murphy
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

Review 10.  Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.

Authors:  Md Abdul Alim Al-Bari
Journal:  J Antimicrob Chemother       Date:  2015-02-17       Impact factor: 5.790

View more
  66 in total

1.  Small molecule grp94 inhibitors block dengue and Zika virus replication.

Authors:  Hussin A Rothan; Yongwang Zhong; Mark A Sanborn; Teow Chong Teoh; Jingjing Ruan; Rohana Yusof; Jun Hang; Mark J Henderson; Shengyun Fang
Journal:  Antiviral Res       Date:  2019-08-14       Impact factor: 5.970

2.  Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.

Authors:  Xu Yang; Jianxun Qi; Ruchao Peng; Lianpan Dai; Ernest A Gould; George F Gao; Po Tien
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 3.  Structure and function of Zika virus NS5 protein: perspectives for drug design.

Authors:  Boxiao Wang; Stephanie Thurmond; Rong Hai; Jikui Song
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

4.  Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus.

Authors:  Jean A Bernatchez; Zunhua Yang; Michael Coste; Jerry Li; Sungjun Beck; Yan Liu; Alex E Clark; Zhe Zhu; Lucas A Luna; Christal D Sohl; Byron W Purse; Rongshi Li; Jair L Siqueira-Neto
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 5.  Mapping the diverse structural landscape of the flavivirus antibody repertoire.

Authors:  Madhumati Sevvana; Richard J Kuhn
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

6.  Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has a Dramatic Effect on Viral Fitness.

Authors:  Ludek Eyer; Hirofumi Kondo; Darina Zouharova; Minato Hirano; James J Valdés; Memi Muto; Tomas Kastl; Shintaro Kobayashi; Jan Haviernik; Manabu Igarashi; Hiroaki Kariwa; Marketa Vaculovicova; Jiri Cerny; Rene Kizek; Andrea Kröger; Stefan Lienenklaus; Milan Dejmek; Radim Nencka; Martin Palus; Jiri Salat; Erik De Clercq; Kentaro Yoshii; Daniel Ruzek
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

7.  Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.

Authors:  Julia Ma; Xuexiang Zhang; Veronica Soloveva; Travis Warren; Fang Guo; Shuo Wu; Huagang Lu; Jia Guo; Qing Su; Helen Shen; Eric Solon; Mary Ann Comunale; Anand Mehta; Ju-Tao Guo; Sina Bavari; Yanming Du; Timothy M Block; Jinhong Chang
Journal:  Antiviral Res       Date:  2017-12-15       Impact factor: 5.970

8.  Identification of small molecule inhibitors targeting the Zika virus envelope protein.

Authors:  Jared Pitts; Chih-Yun Hsia; Wenlong Lian; Jinhua Wang; Marc-Philipp Pfeil; Nicholas Kwiatkowski; Zhengnian Li; Jaebong Jang; Nathanael S Gray; Priscilla L Yang
Journal:  Antiviral Res       Date:  2019-02-13       Impact factor: 5.970

9.  Prodrug Activation by a Viral Protease: Evaluating Combretastatin Peptide Hybrids To Selectively Target Infected Cells.

Authors:  Michael Richter; Mila M Leuthold; Dominik Graf; Ralf Bartenschlager; Christian D Klein
Journal:  ACS Med Chem Lett       Date:  2019-07-18       Impact factor: 4.345

10.  Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors.

Authors:  Szymon Pach; Tim M Sarter; Rafe Yousef; David Schaller; Silke Bergemann; Christoph Arkona; Jörg Rademann; Christoph Nitsche; Gerhard Wolber
Journal:  ACS Med Chem Lett       Date:  2020-03-03       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.